GDO - seriously undervalued gold producer. Probably won't move til qtr production results are out. Check my posts on the GDO thread for full breakdown. All 6 directors have bought on market with large quantities in the last 3 mths. The CEO bought $550,000 this week. Market cap of $300m, will make $60m+ this year...do the math. 33c
PRR - Preparing for phase 3 trial on ovarian cancer. Clinical results out in Q3. NASDAQ listing soon. Has the best team in place out of any biotech I've seen. Highly likely to go all the way. 23c
AHN - massive iron ore resource at fantastic quality. Just took 100% ownership of the resource. Had a massive nickel resource as well. Drilling to start in April, results out May.
